Clinical implications of PTEN loss in prostate cancer (2018)
Source: Nature Reviews Urology. Unidade: FMRP
Subjects: PRÓSTATA, NEOPLASIAS, BIOMARCADORES, GENÉTICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JAMASPISHVILI, Tamara et al. Clinical implications of PTEN loss in prostate cancer. Nature Reviews Urology, v. 15, n. 4, p. 222–234, 2018Tradução . . Disponível em: https://doi.org/10.1038/nrurol.2018.9. Acesso em: 05 ago. 2024.APA
Jamaspishvili, T., Berman, D. M., Ross, A. E., Scher, H. I., Marzo, A. M. D., Squire, J. A., & Lotan, T. L. (2018). Clinical implications of PTEN loss in prostate cancer. Nature Reviews Urology, 15( 4), 222–234. doi:10.1038/nrurol.2018.9NLM
Jamaspishvili T, Berman DM, Ross AE, Scher HI, Marzo AMD, Squire JA, Lotan TL. Clinical implications of PTEN loss in prostate cancer [Internet]. Nature Reviews Urology. 2018 ; 15( 4): 222–234.[citado 2024 ago. 05 ] Available from: https://doi.org/10.1038/nrurol.2018.9Vancouver
Jamaspishvili T, Berman DM, Ross AE, Scher HI, Marzo AMD, Squire JA, Lotan TL. Clinical implications of PTEN loss in prostate cancer [Internet]. Nature Reviews Urology. 2018 ; 15( 4): 222–234.[citado 2024 ago. 05 ] Available from: https://doi.org/10.1038/nrurol.2018.9
